$11.66+0.08 (+0.69%)
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally.
FIGS, Inc. in the Consumer Cyclical sector is trading at $11.66. Wall Street consensus targets $17.62 (8 analysts), implying a +51.2% move over the next 12 months. The stock is currently 33% below its 52-week high of $17.48, remaining 5.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such...
One company powers healthcare apparel with direct sales and rapid growth, while the other scales global basics with steady cash flow and lower valuations.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
A number of stocks jumped in the afternoon session after easing pressure in the bond market and a pullback in oil prices boosted investor sentiment for consumer-facing companies.
FIGS (NYSE:FIGS) reported strong Q1 2026 results, with revenue and profitability exceeding internal expectations. Performance was supported by new product releases, customer growth, and expanding international operations. The company achieved this against a backdrop of tariffs, freight costs, and other macro and operational pressures. For investors watching NYSE:FIGS, the latest quarter lands after a pullback of 29.0% over the past month, alongside a 151.8% gain over the past year. The...
Healthcare apparel company Figs (NYSE:FIGS) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 28% year on year to $159.9 million. Its non-GAAP profit of $0.03 per share was $0.01 above analysts’ consensus estimates.